Figure 1.
Figure 1. Impact of FLT3 mutation status on outcome in APL patients. (A) Relapse risk. (B) Overall survival. (C) Relapse risk in patients with APL and non-APLAML.

Impact of FLT3 mutation status on outcome in APL patients. (A) Relapse risk. (B) Overall survival. (C) Relapse risk in patients with APL and non-APLAML.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal